Renaissance Technologies
CLVS

Renaissance Technologies’s Clovis Oncology, Inc. CLVS Stock Holding History

Renaissance Technologies’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,209,700
Closed -$2.63M – 4546
2022
Q3 		$2.63M Sell
2,209,700
-78,600
-3% -$123K ﹤0.01% 1850
2022
Q2 		$4.12M Buy
2,288,300
+828,400
+57% +$1.22M ﹤0.01% 1702
2022
Q1 		$2.95M Buy
1,459,900
+849,500
+139% +$1.67M ﹤0.01% 1936
2021
Q4 		$1.65M Buy
610,400
+493,700
+423% +$1.83M ﹤0.01% 2286
2021
Q3 		$520K Buy
+116,700
New +$562K ﹤0.01% 2877
2019
Q3 		– Sell
-84,900
Closed -$1.26M – 3811
2019
Q2 		$1.26M Buy
+84,900
New +$1.53M ﹤0.01% 2580
2018
Q2 		– Sell
-258,000
Closed -$13.6M – 3618
2018
Q1 		$13.6M Buy
+258,000
New +$15.1M 0.01% 1175
2017
Q3 		– Sell
-326,200
Closed -$30.5M – 3430
2017
Q2 		$30.5M Buy
326,200
+172,800
+113% +$10.6M 0.04% 608
2017
Q1 		$9.77M Buy
153,400
+71,300
+87% +$4.33M 0.01% 1264
2016
Q4 		$3.65M Buy
+82,100
New +$2.89M 0.01% 1875
2016
Q3 		– Sell
-307,200
Closed -$4.21M – 3538
2016
Q2 		$4.21M Sell
307,200
-208,200
-40% -$3.04M 0.01% 1710
2016
Q1 		$9.9M Buy
+515,400
New +$10.9M 0.02% 1140
2015
Q4 		– Sell
-128,900
Closed -$11.9M – 3482
2015
Q3 		$11.9M Buy
+128,900
New +$11.2M 0.03% 837
2014
Q4 		– Sell
-22,000
Closed -$998K – 3177
2014
Q3 		$998K Buy
+22,000
New +$919K ﹤0.01% 2025
2013
Q4 		– Sell
-14,200
Closed -$863K – 3070
2013
Q3 		$863K Sell
14,200
-7,200
-34% -$511K ﹤0.01% 2074
2013
Q2 		$1.43M Buy
+21,400
New +$962K ﹤0.01% 1767

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Renaissance Technologies's CLVS Position: Q4 2022 in Review

Renaissance Technologies sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 2,209,700 shares — an estimated $2.63M sold.

Renaissance Technologies first reported a position in CLVS in Q2 2013 and held it in 16 quarters. The position peaked at $30.5M in Q2 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Renaissance Technologies reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 2,209,700 Clovis Oncology, Inc. shares in Q4 2022, an estimated $2.63M.
  • Renaissance Technologies first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 16 quarters.
  • Renaissance Technologies's Clovis Oncology, Inc. position peaked at $30.5M in Q2 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.